v3.26.1
Stock-Based Compensation Plans (Tables)
6 Months Ended
Jul. 31, 2026
Stock-Based Compensation Plans  
Schedule of estimated stock-based compensation expense recognized in condensed consolidated statement of operations

  ​ ​ ​

Three Months Ended

  ​ ​ ​

Six Months Ended

  ​ ​ ​

July 31,

  ​ ​ ​

July 31,

  ​ ​ ​

July 31,

  ​ ​ ​

July 31,

2026

2025

2026

2025

Cost of revenues

 

632

 

375

 

1,124

 

692

Sales and marketing

 

2,542

 

1,487

 

4,764

 

2,867

Research and development

 

1,198

 

679

 

2,142

 

1,219

General and administrative

 

3,400

 

1,912

 

6,739

 

4,041

Effect on net income

 

7,772

 

4,453

 

14,769

 

8,819

Schedule of weighted-average assumptions

Six Months Ended

  ​ ​ ​

July 31,

  ​ ​ ​

July 31,

2026

2025

Expected dividend yield (%)

 

Expected volatility (%)

 

29.3

28.3

Risk-free rate (%)

 

3.1

2.8

Expected option life (years)

 

5

5

Schedule of stock option activity

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted-

  ​ ​ ​

Aggregate

Number of

Weighted-

Average

Intrinsic

Stock

Average

Remaining

Value

Options

Exercise

Contractual

(in

Outstanding

Price

Life (years)

millions)

Balance at January 31, 2026

 

1,555,101

$

73.19

 

4.0

$

15.3

Granted

 

778,487

$

68.33

 

 

Exercised

 

(102,170)

$

37.47

 

 

Forfeited

 

(12,392)

$

73.75

 

 

Expired

(3,413)

$

86.16

Balance at July 31, 2026

 

2,215,613

$

73.44

 

4.7

$

19.2

Vested or expected to vest at July 31, 2026

 

2,215,613

$

73.44

 

4.7

$

19.2

Exercisable at July 31, 2026

 

985,658

$

67.76

 

2.9

$

12.9

Schedule of performance share units activity

  ​ ​ ​

  ​ ​ ​

Weighted-

  ​ ​ ​

Weighted-

  ​ ​ ​

Aggregate

Average

Average

Intrinsic

Number of

Granted

Remaining

Value

PSUs

Date Fair

Contractual

(in

Outstanding

Value

Life (years)

millions)

Balance at January 31, 2026

 

1,012,268

$

69.58

 

4.4

$

73.9

Granted

149,664

$

101.51

Performance units issued

20,688

$

103.33

Exercised

(100,242)

$

12.09

Balance at July 31, 2026

1,082,378

$

69.36

5.2

$

82.3

Vested or expected to vest at July 31, 2026

 

1,082,378

$

69.36

 

5.2

$

82.3

Exercisable at July 31, 2026

 

762,185

$

52.62

 

3.7

$

58.0

Schedule of restricted share units activity

  ​ ​ ​

  ​ ​ ​

Weighted-

  ​ ​ ​

Weighted-

  ​ ​ ​

Aggregate

Average

Average

Intrinsic

Number of

Granted

Remaining

Value

RSUs

Date Fair

Contractual

(in

Outstanding

Value

Life (years)

millions)

Balance at January 31, 2026

 

473,999

$

56.92

 

5.0

$

34.6

Granted

 

96,884

$

68.11

 

 

Exercised

(38,456)

$

17.91

Balance at July 31, 2026

 

532,427

$

62.10

 

5.8

$

40.5

Vested or expected to vest at July 31, 2026

 

532,427

$

62.10

 

5.8

$

40.5

Exercisable at July 31, 2026

 

377,633

$

55.08

 

4.4

$

28.7

Schedule of cash settled restricted share unit plan activity

  ​ ​ ​

  ​ ​ ​

Weighted-

Average

Number of

Remaining

CRSUs

Contractual

Outstanding

Life (years)

Balance at January 31, 2026

 

12,957

 

1.7

Granted

15,394

Vested and settled in cash

(4,111)

Balance at July 31, 2026

24,240

2.3

Non-vested at July 31, 2026

 

24,240

 

2.3